Filing Details
- Accession Number:
- 0001127602-20-022203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-29 16:09:17
- Reporting Period:
- 2020-07-27
- Accepted Time:
- 2020-07-29 16:09:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1745891 | A. Syed Jafry | 168 Third Avenue Waltham MA 02451 | Sr. Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-27 | 5,638 | $129.77 | 26,657 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-27 | 2,100 | $414.32 | 24,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-27 | 3,225 | $415.44 | 21,332 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-27 | 313 | $415.88 | 21,019 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-27 | 6,200 | $157.68 | 27,219 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-27 | 6,200 | $415.76 | 21,019 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-27 | 4,575 | $210.68 | 25,594 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-27 | 3,875 | $414.17 | 21,719 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-27 | 700 | $415.15 | 21,019 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-27 | 4,100 | $253.99 | 25,119 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-27 | 4,100 | $414.24 | 21,019 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-27 | 5,638 | $0.00 | 5,638 | $129.77 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-27 | 6,200 | $0.00 | 6,200 | $157.68 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-27 | 4,575 | $0.00 | 4,575 | $210.68 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-27 | 4,100 | $0.00 | 4,100 | $253.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-24 | No | 4 | M | Direct | |
| 6,200 | 2024-02-28 | No | 4 | M | Direct | |
| 9,150 | 2025-02-27 | No | 4 | M | Direct | |
| 12,300 | 2026-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 41 | Indirect | by 401K |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.785 to $414.66, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.84 to $415.815, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.86 to $416.17, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.74 to $414.545, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.06 to $415.29, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.81 to $414.71, inclusive.
- The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 28, 2018, 2019 and 2020, and the remaining one-quarter will vest on February 28, 2021.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 27, 2019 and February 27, 2020, and the remaining two quarters will vest on February 27, 2021 and February 27, 2022.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 26, 2020, and the remaining three quarters will vest on February 26, 2021, 2022 and 2023.
Billionaire Hedge Funds
